{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:41:17Z","timestamp":1791222077272,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Key Projects of Gannan Medical University","award":["ZD201913"],"award-info":[{"award-number":["ZD201913"]}]},{"name":"Health and Planning Commission Research Project of Jiangxi Province","award":["20204530"],"award-info":[{"award-number":["20204530"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clml.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T09:42:57Z","timestamp":1592127777000},"page":"e858-e863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell Lymphoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Jin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.06.005_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1586\/14737140.2015.1023712","article-title":"New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy","volume":"15","author":"Chihara","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clml.2020.06.005_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2020.06.005_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.clml.2020.06.005_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001622-200109000-00003","article-title":"Diffuse large cell lymphoma","volume":"13","author":"Coiffier","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clml.2020.06.005_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3960\/jslrt.56.71","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"56","author":"Dobashi","year":"2016","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.clml.2020.06.005_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","article-title":"Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review","volume":"14","author":"Camicia","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clml.2020.06.005_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1055-9965.EPI-15-0921","article-title":"Contributions of subtypes of non-Hodgkin lymphoma to mortality trends","volume":"25","author":"Howlader","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 4","key":"10.1016\/j.clml.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/annonc\/mdn195","article-title":"Radiotherapy in non-Hodgkin lymphomas","volume":"19","author":"Gospodarowicz","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4065\/80.8.1087","article-title":"Non-Hodgkin lymphoma: diagnosis and treatment","volume":"80","author":"Ansell","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2020.06.005_bib12","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","article-title":"Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma","volume":"107","author":"Moser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.06.005_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hon.2607","article-title":"Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype","volume":"37","author":"Abuamsha","year":"2019","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib14","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin\u2019s lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"Volkova","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.clml.2020.06.005_bib16","first-page":"103","article-title":"Long-term toxicity of chemotherapy and radiotherapy in lymphoma survivors: optimizing treatment for individual patients","volume":"13","author":"Hodgson","year":"2015","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2020.06.005_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00277-018-3571-7","article-title":"Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival?","volume":"98","author":"Chihara","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.06.005_bib20","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/cncr.30739","article-title":"Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era","volume":"123","author":"Howlader","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.06.005_bib21","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood-2011-10-388470","article-title":"Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma","volume":"119","author":"Klapper","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.06.005_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2010.30.2075","article-title":"Impact of age at diagnosis on prostate cancer treatment and survival","volume":"29","author":"Bechis","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2015-04-639336","article-title":"Risk-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma: analysis from a multicenter study","volume":"126","author":"Yang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.06.005_bib24","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1200\/JCO.2016.68.9372","article-title":"Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems","volume":"34","author":"Adam","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A\u00a0predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.06.005_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A\u00a0prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0033354919878158","article-title":"Black and white differences in life expectancy in 4 US states, 1969-2013","volume":"134","author":"Kaufman","year":"2019","journal-title":"Public Health Rep"},{"key":"10.1016\/j.clml.2020.06.005_bib28","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1371\/journal.pmed.0050066","article-title":"The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States","volume":"5","author":"Ezzati","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.clml.2020.06.005_bib29","doi-asserted-by":"crossref","first-page":"e1000248","DOI":"10.1371\/journal.pmed.1000248","article-title":"The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States","volume":"7","author":"Danaei","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.clml.2020.06.005_bib30","doi-asserted-by":"crossref","first-page":"e32930","DOI":"10.1371\/journal.pone.0032930","article-title":"Geographic and racial variation in premature mortality in the U.S.: analyzing the disparities","volume":"7","author":"Cullen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2020.06.005_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2018.05.006","article-title":"Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: a Danish population-based cohort study","volume":"99","author":"Juul","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clml.2020.06.005_bib32","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.2017.72.4211","article-title":"Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors","volume":"35","author":"Salz","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.005_bib33","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.ijcard.2013.08.033","article-title":"Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study","volume":"168","author":"Jurczak","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clml.2020.06.005_bib34","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2013.01.054","article-title":"Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects","volume":"61","author":"Savji","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clml.2020.06.005_bib35","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamacardio.2019.3891","article-title":"Association of cardiovascular disease with premature mortality in the United States","volume":"4","author":"Chen","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clml.2020.06.005_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12872-017-0508-3","article-title":"Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study","volume":"17","author":"Kvakkestad","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.clml.2020.06.005_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1089\/jwh.2016.6103","article-title":"Marital status, cardiovascular diseases, and cardiovascular risk factors: a review of the evidence","volume":"26","author":"Manfredini","year":"2017","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.clml.2020.06.005_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jech.49.5.482","article-title":"Health behaviours explain part of the differences in self reported health associated with partner\/marital status in The Netherlands","volume":"49","author":"Joung","year":"1995","journal-title":"J\u00a0Epidemiol Community Health"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020303037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020303037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:35Z","timestamp":1761870875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020303037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2152265020303037"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.06.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}